A mutation in IDH1 is sufficient to induce genome-wide changes in DNA methylation patterns, including the glioma cytosine phosphate guanine (CpG) island methylator phenotype (G-CIMP) found in a subset of gliomas, which is associated with diverse transcriptional changes [17,25]. The gene discussed is IDH1; the disease is central nervous system cancer.